GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Institutional Ownership

Valbiotis (XPAR:ALVAL) Institutional Ownership : 7.72% (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Valbiotis's institutional ownership is 7.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Valbiotis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Valbiotis's Float Percentage Of Total Shares Outstanding is 0.00%.


Valbiotis Institutional Ownership Historical Data

The historical data trend for Valbiotis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Institutional Ownership Chart

Valbiotis Historical Data

The historical data trend for Valbiotis can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 7.98 7.98 7.90 8.26 8.24 6.66 7.52 7.82 7.72 7.72

Valbiotis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Valbiotis (XPAR:ALVAL) Business Description

Traded in Other Exchanges
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines